HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases.

Abstract
Expression of ALK protein by lymphoid cells and the description of variant anaplastic lymphoma kinase (ALK) translocations have typically been restricted to cases of T-cell and null anaplastic large-cell lymphoma (ALCL). All such cases result from a novel fusion created by the ALK gene on chromosome 2p23 and NPM on 5q35 or other variant translocation partners. A rare variant of diffuse large B-cell lymphoma (DLBCL), originally described in 1997, was thought to overexpress full-length ALK in contrast to a chimeric protein characteristic of ALCL. However, full-length ALK protein lacks tyrosine kinase activity and thus the mechanism of oncogenesis has remained elusive. We describe 6 cases of ALK+ DLBCL characterized by a simple or complex t(2;17)(p23;q23) involving the clathrin gene (CLTC) at chromosome band 17q23 and the ALK gene at chromosome band 2p23. All cases were studied using fluorescence in situ hybridization (FISH), complemented in one case with standard cytogenetic analysis, multicolor karyotyping (M-FISH), and reverse transcriptase-polymerase chain reaction. These results clearly demonstrate that most cases of ALK+ DLBCL share the same mechanism of deregulated ALK expression. Moreover, these results demonstrate the presence of CLTC-ALK fusions in these tumors and extend the list of diseases associated with this genetic abnormality to include classical T-cell or null ALCL, ALK+ DLBCL, and inflammatory myofibroblastic tumors.
AuthorsRandy D Gascoyne, Laurence Lamant, Jose I Martin-Subero, Valia S Lestou, Nancy Lee Harris, Hans-Konrad Müller-Hermelink, John F Seymour, Lynda J Campbell, Douglas E Horsman, Isabelle Auvigne, Estelle Espinos, Reiner Siebert, Georges Delsol
JournalBlood (Blood) Vol. 102 Issue 7 Pg. 2568-73 (Oct 01 2003) ISSN: 0006-4971 [Print] United States
PMID12763927 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Clathrin
  • Oncogene Proteins, Fusion
  • RNA, Messenger
  • oncoprotein CLTCL-ALK
  • ALK protein, human
  • Anaplastic Lymphoma Kinase
  • Protein-Tyrosine Kinases
  • Receptor Protein-Tyrosine Kinases
Topics
  • Anaplastic Lymphoma Kinase
  • Clathrin (genetics)
  • Gene Expression Regulation, Neoplastic
  • Gene Rearrangement (genetics)
  • Humans
  • Immunophenotyping
  • In Situ Hybridization, Fluorescence (methods)
  • Lymphoma, B-Cell (genetics, pathology)
  • Lymphoma, Large B-Cell, Diffuse (genetics, pathology)
  • Oncogene Proteins, Fusion (genetics)
  • Protein-Tyrosine Kinases (genetics)
  • RNA, Messenger (analysis)
  • Receptor Protein-Tyrosine Kinases
  • Reverse Transcriptase Polymerase Chain Reaction
  • Translocation, Genetic
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: